Open Access 09-01-2021 | Correction
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 8/2021
Log in om toegang te krijgen